EUVIMEDEUVIMED entdecken
Multizentrische Studie

Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer

Sophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, Marco Moschini, Francesco Soria, David D'Andrea, Shahrokh F Shariat, Alexandra Budowski, Cédric Poyet, Mathieu Roumiguie, Mario Álvarez Maestro, Alberto Briganti und 12 weitere

World Journal of Urology · 13.01.2026 · 44 (1)

DOI: 10.1007/s00345-025-06170-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift World Journal of Urology, online erschienen am 13.01.2026. Verfasst von Sophie Régnier und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Assistance Publique-Hôpitaux de Paris Nord, Bichat Claude-Bernard Hospital, University Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy, Second-Look Surgery. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the oncological outcomes of second-look transurethral resection of bladder tumor (TURBT) in patients with a high grade (HG) Ta non-muscle invasive bladder cancer (NMIBC). PATIENTS AND METHODS: We conducted a real-life multicenter study including all consecutive patients with HG Ta NMIBC, with or without second TURBT. Oncological outcomes included disease recurrence and progression. Multivariable Cox regression analyses were used to identify the independent predictors of bladder recurrence and progression. RESULTS: Of the 447 patients with HG Ta NMIBC, 240 (53.7%) underwent a second TURBT, while 207 (46.3%) did not. After a median follow-up of 30 [15-54] months, Kaplan Meier curves showed that a second TURBT was associated with significantly higher 5-year recurrence-free survival (RFS) rate but similar 5-year progression-free survival (PFS) rate. Multivariable Cox regression analysis reported that a second TURBT was not significantly associated with RFS (HR = 0.76; 95% CI=[0.50-1.16]; p = 0.2) and PFS (HR = 0.76; 95% CI=[0.37-1.56]; p = 0.4). Among the 240 patients underwent second TURBT, 151 (63%) had no residual disease. The 5-year RFS and 5-year PFS were significantly higher in patients without residual tumor at second TURBT. Multivariable Cox regression analysis confirmed that residual bladder tumor at second TURBT was the only independent predictor of bladder recurrence (HR = 1.28; p = 0.02) and progression (HR = 1.38; p = 0.03). CONCLUSION: Based on the results of our multicenter retrospective study, a systematic second TURBT in HG Ta NMIBC does not significantly improve oncologic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCystectomySecond-Look SurgeryHumansMaleFemaleAgedMiddle AgedNeoplasm InvasivenessRetrospective StudiesNeoplasm GradingUrethraNeoplasm Recurrence, LocalAged, 80 and overDisease ProgressionNon-Muscle Invasive Bladder Neoplasms

Stichwörter der Autor:innen

Detrusor muscleHigh-gradeNon-muscle invasive bladder cancerSecond lookTa

Autor:innen und Institutionen

  • Department of Urology, Assistance Publique-Hôpitaux de Paris Nord, Bichat Claude-Bernard Hospital, University Paris Cité, Paris, France.
  • Unit of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.
  • Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Department of Anesthesiology, University of Zurich, University Hospital Zurich, Zurich, 8091, Switzerland.

Zitieren

APA

Régnier, S., Gabriel, P. E., Ouzaid, I., Moschini, M., Soria, F., D'Andrea, D., Shariat, S. F., Budowski, A., Poyet, C., Roumiguie, M., Maestro, M. Á., Briganti, A., Krajewski, W., Hendricksen, K., Veerman, H., Afferi, L., Mattei, A., Di Bona, C., Zamboni, S., …, & Xylinas, E. (2026). Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer. World Journal of Urology, 44(1). https://doi.org/10.1007/s00345-025-06170-7

Vancouver

Régnier S, Gabriel PE, Ouzaid I, Moschini M, Soria F, D'Andrea D, et al. Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer. World Journal of Urology. 2026;44(1). doi:10.1007/s00345-025-06170-7

BibTeX
@article{Rgnier2026,
  author = {Régnier, Sophie and Gabriel, Pierre-Etienne and Ouzaid, Idir and Moschini, Marco and Soria, Francesco and D'Andrea, David and Shariat, Shahrokh F and Budowski, Alexandra and Poyet, Cédric and Roumiguie, Mathieu and Maestro, Mario Álvarez and Briganti, Alberto and Krajewski, Wojciech and Hendricksen, Kees and Veerman, Hans and Afferi, Luca and Mattei, Agostino and Di Bona, Carlo and Zamboni, Stefania and Simeone, Claudio and Thenault, Ronan and Verhoest, Gregory and Gontero, Paolo and Xylinas, Evanguelos},
  title = {Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer},
  journal = {World Journal of Urology},
  year = {2026},
  volume = {44},
  number = {1},
  doi = {10.1007/s00345-025-06170-7}
}
Kostenlos starten →